Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 197

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy

Open access
Chen, Tingyu, Li, Xiang, Li, Yingxue, Xia, Eryu, Qin, Yong, Liang, Shaoshan, Xu, Feng, Liang, Dandan, Zeng, Caihong, Liu, Zhihong · 2019 · American Journal of Kidney Diseases

Abstract

RATIONALE & OBJECTIVE Immunoglobulin A nephropathy (IgAN) is common worldwide and has heterogeneous phenotypes. Predicting long-term outcomes and stratifying risk are important for clinical decision making and designing future clinical trials. STUDY DESIGN Multicenter retrospective cohort study of 2,047 patients with IgAN. SETTING & PARTICIPANTS Derivation and validation cohorts composed of 1,022 Chinese patients with IgAN from a single center and 1,025 patients with IgAN from 18 renal centers, respectively. PREDICTORS 36 characteristics, including demographic, clinical, and pathologic variables. OUTCOMES Combined event of end-stage kidney disease or 50% reduction in estimated glomerular filtration rate within 5 years after diagnostic kidney biopsy. ANALYTICAL APPROACH A gradient tree boosting method implemented in the eXtreme Gradient Boosting (XGBoost) system was used to select the 10 most important variables from 36 candidate variables. Stepwise Cox regression analysis was used to derive a simplified scoring scale model (SSM) based on these 10 variables. Model discrimination and calibration were assessed using the C statistic and Hosmer-Lemeshow test. Risk stratification of the SSM was evaluated using Kaplan-Meier analysis. RESULTS In the derivation and validation cohorts, 74 and 114 patients reached the outcome, respectively. XGBoost predicted the outcome with a C statistic of 0.84 (95% CI, 0.80-0.88) for the validation cohort. The SSM included 3 variables: urine protein excretion, global sclerosis, and tubular atrophy/interstitial fibrosis. Using Kaplan-Meier analysis, the SSM identified significant risk stratification (P < 0.001). LIMITATIONS Retrospective study design, application for other ethnic groups needs to be verified. CONCLUSIONS A prediction model using routinely available characteristics and based on the combination of a machine learning algorithm and survival analysis can stratify risk for kidney disease progression in the setting of IgAN. An online calculator, the Nanjing IgAN Risk Stratification System, permits easy implementation of this model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2019.02.016

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 197

Metadata

Authors
Chen, T., Li, X., Li, Y., Xia, E., Qin, Y., Liang, S., Xu, F., Liang, D., Zeng, C., & Liu, Z.
Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
2019-09
Volume
74
Issue
3
Pages
300-309
ISSN
0272-6386 (ISSN-L)
OpenAlex
W2941163443
Cited by
197
References
7
FWCI
15.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy. https://app.cochat.ai/papers/10.1053/j.ajkd.2019.02.016
The paper
Chen, T., Li, X., Li, Y., Xia, E., Qin, Y., Liang, S., Xu, F., Liang, D., Zeng, C., & Liu, Z. (2019). Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2019.02.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.